Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of rat cirrhotic liver treated with angiogenesis inhibitors


ABSTRACT: Background and aims: There are considerable evidences demonstrating that angiogenesis and chronic inflammation are mutually dependent. However, although cirrhosis progression is characterized with a chronic hepatic inflammatory process, this connection is not sufficiently explored as a therapeutic strategy. Therefore, this study was aimed to assess the potential benefits of targeting angiogenesis in cirrhotic livers to modulate inflammation and fibrosis. For this purpose, we evaluate the therapeutic utility of angiogenesis inhibitors. Methods: The in vivo effects of angiogenesis inhibitors were monitored in liver of cirrhotic rats by measuring angiogenesis, inflammatory infiltrate, fibrosis, a-smooth muscle actin (a-SMA) accumulation, differential gene expression (by microarrays), and portal pressure. Results: Cirrhosis progression was associated with a significant enhancement of vascular density and expression of vascular endothelial growth factor-A (VEGF-A), angiopoietin-1, angiopoietin-2 and placental growth factor (PlGF) in cirrhotic livers. The newly formed hepatic vasculature expressed vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1). Interestingly, the expression of these adhesion molecules correlated well with local inflammatory infiltrate. Livers of cirrhotic rats treated with angiogenesis inhibitors presented a significant decrease in hepatic vascular density, inflammatory infiltrate, a-SMA abundance, collagen expression and portal pressure. Conclusion: Angiogenesis inhibitors may offer a potential novel therapy for cirrhosis due to its multiple mechanisms of action against angiogenesis, inflammation and fibrosis in cirrhotic livers. Experiment Overall Design: RNA from liver of 4 non-treated cirrhotic rats or 4 rats treated with angiogenesis inhibitors was hybridized to 8 high-density oligonucleotide microarray (Rat2302, Affymetrix, Santa Clara, CA)

ORGANISM(S): Rattus norvegicus

SUBMITTER: Manuel Morales-Ruiz 

PROVIDER: E-GEOD-6929 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

Tugues Sònia S   Fernandez-Varo Guillermo G   Muñoz-Luque Javier J   Ros Josefa J   Arroyo Vicente V   Rodés Juan J   Friedman Scott L SL   Carmeliet Peter P   Jiménez Wladimiro W   Morales-Ruiz Manuel M  

Hepatology (Baltimore, Md.) 20071201 6


<h4>Unlabelled</h4>Liver cirrhosis is a very complex disease in which several pathological processes such as inflammation, fibrosis, and pathological angiogenesis are closely integrated. We hypothesized that treatment with pharmacological agents with multiple mechanisms of action will produce superior results to those achieved by only targeting individual mechanisms. This study thus evaluates the therapeutic use of the multitargeted receptor tyrosine kinase inhibitor Sunitinib (SU11248). The in  ...[more]

Similar Datasets

2007-10-18 | GSE6929 | GEO
| PRJNA98087 | ENA
2019-03-22 | GSE122822 | GEO
2016-12-22 | GSE84178 | GEO
2007-09-05 | E-GEOD-1843 | biostudies-arrayexpress
2023-11-20 | PXD035024 | Pride
2011-11-02 | E-GEOD-22977 | biostudies-arrayexpress
| phs001106 | dbGaP
2013-08-15 | E-GEOD-49012 | biostudies-arrayexpress
2021-09-11 | GSE125955 | GEO